Retrieve available abstracts of 103 articles: HTML format
Single Articles
July 2025
PATEL H, DeMasters D, Tofferi J Antinuclear Antibody Multiplex Utilization Across a Large Federal Hospital
System: An Investigation of Ordering Practices and Rheumatologic Outcomes.
J Rheumatol. 2025;52:721-727. PubMedAbstract available
KHAROUF F, Mehta P, Alhadri A, Li Q, et al Comparative Analysis of Damage Accrual in Lupus Nephritis Stratified by
Biological Sex.
J Rheumatol. 2025 Jul 1:jrheum.2025-0302. doi: 10.3899/jrheum.2025-0302. PubMedAbstract available
KHAROUF F, Mehta P, Li Q, Gladman DD, et al Comparison of Lupus Nephritis Onset Before and After Age 50: Impact on
Presentation and Outcomes in an Inception Cohort.
J Rheumatol. 2025 Jul 1:jrheum.2024-1278. doi: 10.3899/jrheum.2024-1278. PubMedAbstract available
TEAW S, Shojaee A, Carnaru M, Hinchcliff M, et al The Risk and Time Course for Autoimmune Rheumatic Disease Development in Patients
With Raynaud Phenomenon.
J Rheumatol. 2025 Jul 1:jrheum.2024-0954. doi: 10.3899/jrheum.2024-0954. PubMed
COHEN-HAGAI K, Saban M, Benchetrit S, Bar-Ziv D, et al Prevalence, Risk Factors, and Outcomes of Chronic Kidney Disease in Systemic
Lupus Erythematosus Patients with and without Lupus Nephritis.
J Rheumatol. 2025 Jul 1:jrheum.2024-1087. doi: 10.3899/jrheum.2024-1087. PubMedAbstract available
JUNEK ML, Okaj I, Patel S, Hu A, et al Multivariable models to predict a diagnosis of Giant Cell Arteritis: systematic
review and meta-analysis.
J Rheumatol. 2025 Jul 1:jrheum.2022-1204. doi: 10.3899/jrheum.2022-1204. PubMedAbstract available
SMITH JD, Pan B, Keeling S Identifying the State of Mental Health Care in Canadian Adults with Systemic
Lupus Erythematosus.
J Rheumatol. 2025 Jul 1:jrheum.2025-0089. doi: 10.3899/jrheum.2025-0089. PubMedAbstract available
May 2025
GUNGORER V, Celik IK, Artac H, Celikel Acar B, et al OTULIN-Related Autoinflammatory Syndrome With a Novel Mutation Treated With Tumor
Necrosis Factor Inhibitor Therapy: A Rare Case Report.
J Rheumatol. 2025 May 15:jrheum.2024-1141. doi: 10.3899/jrheum.2024-1141. PubMed
PIRES DA ROSA G, Granja BV, Azevedo F, Magina S, et al Pyoderma Gangrenosum-Associated Autoinflammatory Syndrome With Skin Abscesses:
Successful Treatment With Anti-Interleukin 1 Therapy.
J Rheumatol. 2025 May 15:jrheum.2025-0036. doi: 10.3899/jrheum.2025-0036. PubMed
RODRIGUEZ-REYNA TS The Nuances of Shared Autoimmunity and the Singularity of Mixed Connective Tissue
Disease.
J Rheumatol. 2025 May 15:jrheum.2025-0463. doi: 10.3899/jrheum.2025-0463. PubMed
JIANG Z, Barra L Does Prior Authorization for Tocilizumab Lead to Unacceptable Treatment Delays in
Giant Cell Arteritis?
J Rheumatol. 2025 May 15:jrheum.2025-0423. doi: 10.3899/jrheum.2025-0423. PubMed
PLANTINGA LC, Roberts ET, Hoge C, Pearce BD, et al Indicators of Functional Disability by Receipt of Disability Benefits Among
Individuals With Systemic Lupus Erythematosus.
J Rheumatol. 2025;52:479-488. PubMedAbstract available
PATTERSON SL, Ruvalcaba D, Issa A, Rai K, et al Experiences with Complementary and Integrative Health Among People with
Rheumatoid Arthritis and Systemic Lupus Erythematosus: A Qualitative Study.
J Rheumatol. 2025 May 1:jrheum.2024-1218. doi: 10.3899/jrheum.2024-1218. PubMedAbstract available
KIM H Interferon Response Gene Score in Juvenile Dermatomyositis.
J Rheumatol. 2025 May 1:jrheum.2025-0395. doi: 10.3899/jrheum.2025-0395. PubMed
March 2025
FETERMAN JIMENEZ D, Thomason JL, Liew JW, Ferguson S, et al Delays in Tocilizumab Therapy for Patients With Giant Cell Arteritis in the
United States.
J Rheumatol. 2025 Mar 15:jrheum.2024-0988. doi: 10.3899/jrheum.2024-0988. PubMedAbstract available
ICHIKAWA T, Kishida D, Shimojima Y, Yajima N, et al Trust in Health Information Sources Among Patients with Systemic Lupus
Erythematosus in the Social Networking Era: The TRUMP(2)-SLE Study.
J Rheumatol. 2025 Mar 15:jrheum.2024-1088. doi: 10.3899/jrheum.2024-1088. PubMedAbstract available
MACMAHON J, Massumi M, Duong TT, Garrett RH, et al Interferon Response Gene Score in Juvenile Dermatomyositis Correlates Strongly
with Disease Activity.
J Rheumatol. 2025 Mar 15:jrheum.2024-0806. doi: 10.3899/jrheum.2024-0806. PubMedAbstract available
GENER KR, Simakova E, Handal M Concurrent IgG4-Related Disease and Giant Cell Arteritis: A Rare Case Study.
J Rheumatol. 2025 Mar 1:jrheum.2024-0861. doi: 10.3899/jrheum.2024-0861. PubMed
AGUILA T, Madan R, Palmer MB, Derk CT, et al Zebra Bodies in Kidney Biopsy: Drug-Induced Phospholipidosis in a Patient With
Systemic Lupus Erythematosus.
J Rheumatol. 2025 Mar 1:jrheum.2024-1312. doi: 10.3899/jrheum.2024-1312. PubMed
February 2025
HIGHLAND KB, Chakravarty R, Georgi S, Han M, et al Patient Perspectives and Clinical Insights Into the Diagnostic Journey From
Connective Tissue Disease to Pulmonary Arterial Hypertension.
J Rheumatol. 2025 Feb 20:jrheum.2024-0613. doi: 10.3899/jrheum.2024-0613. PubMed
AFLAKI M, Bargman JM Urine Protein Tests in Systematic Lupus Erythematosus: What Do They Mean?
J Rheumatol. 2025 Feb 15:jrheum.2024-0910. doi: 10.3899/jrheum.2024-0910. PubMedAbstract available
STOUSTRUP P, Kellenberger CJ, Host C, Kuseler A, et al Effects of Biologics on Temporomandibular Joint Inflammation in Juvenile
Idiopathic Arthritis.
J Rheumatol. 2025;52:173-180. PubMedAbstract available
MUMTAZ S, Koster MJ, Warrington KJ Novel Photon-Counting Computed Tomography for the Evaluation of Large-Vessel
Giant Cell Arteritis.
J Rheumatol. 2025 Feb 1:jrheum.2024-1156. doi: 10.3899/jrheum.2024-1156. PubMed
NISHAT F, Golding M, Merrill K, Protudjer JLP, et al Lived Education Experience of Young Adults with Childhood- and Adult-onset
Systemic Lupus Erythematosus: A Multi-Centre Canadian Qualitative Study.
J Rheumatol. 2025 Feb 1:jrheum.2024-0695. doi: 10.3899/jrheum.2024-0695. PubMedAbstract available
ABEL G, Ansari MQ, Snyder MR, Tebo AE, et al Historical Perspective on Antinuclear Antibody Testing.
J Rheumatol. 2025 Feb 1:jrheum.2023-1121. doi: 10.3899/jrheum.2023-1121. PubMedAbstract available
December 2024
GONZALEZ-GAY MA, Castaneda S, Ferraz-Amaro I Managing Giant Cell Arteritis With Tocilizumab: Relapses and Adverse Events.
J Rheumatol. 2024 Dec 15:jrheum.2024-1204. doi: 10.3899/jrheum.2024-1204. PubMed
HASLAK F, Kilic H, Sahin S, Hotaman B, et al Children With Type I Interferonopathy: Commonalities and Diversities in a Large
Patient Cohort.
J Rheumatol. 2024;51:1208-1217. PubMedAbstract available
MAILLE M, Tounkara BS, Vagner D, Bagny K, et al Epidemiology of isolated Cutaneous Lupus Erythematosus in the multiethnic
population of Reunion Island (France): a retrospective multicentric study.
J Rheumatol. 2024 Dec 1:jrheum.2024-0661. doi: 10.3899/jrheum.2024-0661. PubMedAbstract available
November 2024
NAGASE FN, Fukui S, Takizawa N, Yamaguchi T, et al Tocilizumab for Giant Cell Arteritis: Clinical Outcomes Following Relapses and
Tocilizumab Discontinuation Due to Adverse Events.
J Rheumatol. 2024 Nov 15:jrheum.2024-0612. doi: 10.3899/jrheum.2024-0612. PubMedAbstract available
PARIMI VP, Ravindran V Cardiovascular Health and Adverse Pregnancy Outcomes in Autoimmune Rheumatic
Diseases.
J Rheumatol. 2024 Nov 15:jrheum.2024-0828. doi: 10.3899/jrheum.2024-0828. PubMed
RANDELL RL, Reeve BB, Weitzman ER, von Scheven E, et al Pain Interference in Juvenile Idiopathic Arthritis.
J Rheumatol. 2024;51:1119-1124. PubMedAbstract available
IMAI Y, Ota Y, Matsumoto K, Akiyama M, et al Performance of the 2022 ACR/EULAR Classification Criteria in Comparison With the
European Medicines Agency Algorithm in Antineutrophil Cytoplasmic
Antibody-Associated Vasculitis.
J Rheumatol. 2024;51:1102-1110. PubMedAbstract available
BRUNNER HI, Pacheco-Tena C, Louw I, Vega-Cornejo G, et al Intravenous Golimumab in Children With Polyarticular-Course Juvenile Idiopathic
Arthritis: Long-Term Extension of an Open-Label Phase III Study.
J Rheumatol. 2024;51:1125-1134. PubMedAbstract available
LIEBER SB, Young SR, Shea Y, Gottesman SP, et al The Lived Experiences of Older Adults with Systemic Lupus Erythematosus: Patient
Perspectives.
J Rheumatol. 2024 Nov 1:jrheum.2024-0478. doi: 10.3899/jrheum.2024-0478. PubMedAbstract available
ARDALAN K, Rider LG Ringing in the Patient Voice: Measuring Patients' Lived Experience of
Dermatomyositis Symptoms.
J Rheumatol. 2024 Nov 1:jrheum.2024-0951. doi: 10.3899/jrheum.2024-0951. PubMedAbstract available
JIANG Y, Duarte-Garcia A, Putman M, Gazeley D, et al Incidence of Pneumocystis jirovecii Pneumonia and Prophylaxis-Associated Adverse
Events Among Patients with Systemic Lupus Erythematosus.
J Rheumatol. 2024 Nov 1:jrheum.2023-1038. doi: 10.3899/jrheum.2023-1038. PubMedAbstract available
October 2024
LIU X, Zhang J, Xu H, Kuang W, et al Epidemiological characteristics of patients with juvenile dermatomyositis in
China: a multicenter study.
J Rheumatol. 2024 Oct 15:jrheum.2024-0003. doi: 10.3899/jrheum.2024-0003. PubMedAbstract available
ZAREK J, Lee J, Harakati D, Spitzer K, et al Vitamin K Antagonists for Pregnant Women With Antiphospholipid Antibodies: A
Scoping Review.
J Rheumatol. 2024;51:964-972. PubMedAbstract available
OCAMPO-TORRES MC, Hernandez-Molina G, Criales-Vera S, Sanchez-Guerrero J, et al Coronary Artery Calcification Progression in Patients With Systemic Lupus
Erythematosus.
J Rheumatol. 2024;51:991-996. PubMedAbstract available
NIETO RE, Alarcon GS, Arnaud L, Pons-Estel GJ, et al Finding the Role of Anifrolumab in the New Paradigm of Systemic Lupus
Erythematosus Treatment.
J Rheumatol. 2024 Oct 1:jrheum.2024-0900. doi: 10.3899/jrheum.2024-0900. PubMedAbstract available
September 2024
VYZHGA Y, Doria AS, Feldman BM, Tse SM, et al Mining for Gems: Early Detection of Calcinosis in Juvenile Dermatomyositis Using
Low-Dose Computed Tomography.
J Rheumatol. 2024 Sep 15:jrheum.2024-0594. doi: 10.3899/jrheum.2024-0594. PubMedAbstract available
KUWANA M, Wakasugi N, Hashida T, Uno S, et al Update on Tacrolimus in Patients With Interstitial Pneumonia Associated With
Polymyositis or Dermatomyositis: 3-Year Postmarketing Surveillance Follow-Up in
Japan.
J Rheumatol. 2024 Sep 15:jrheum.2024-0379. doi: 10.3899/jrheum.2024-0379. PubMedAbstract available
AN J, Marwaha A, Laxer RM Autoinflammatory Diseases: A Review.
J Rheumatol. 2024;51:848-861. PubMedAbstract available
August 2024
AIRES BP, Wobma H, Samad A, Chandler MT, et al Severe Features of Systemic Juvenile Idiopathic Arthritis in Patients With
Congenital Heart Disease.
J Rheumatol. 2024;51:811-817. PubMedAbstract available
KARABUKAYEVA A, Hearld LR, Choi S, Singh JA, et al Patient Perspectives on a Decision Aid for Systemic Lupus Erythematosus: Insights
and Future Considerations.
J Rheumatol. 2024;51:798-803. PubMedAbstract available
PEDERSEN MJ, Host C, Hansen SN, Klotsche J, et al School Well-Being and Academic Performance of Children With Juvenile Idiopathic
Arthritis: A National Register-Based Study.
J Rheumatol. 2024;51:804-810. PubMedAbstract available
GOLDER V, Kandane-Rathnayake R, Louthrenoo W, Chen YH, et al Comparison of Attainment and Protective Effects of Lupus Low Disease Activity
State in Patients With Newly Diagnosed Versus Established Systemic Lupus
Erythematosus.
J Rheumatol. 2024;51:790-797. PubMedAbstract available
OKITA Y, Okamoto M, Fujimoto J, Kumanogoh A, et al Pneumocephalus and Cerebral Abscess in Granulomatosis With Polyangiitis.
J Rheumatol. 2024;51:832. PubMed
YAMADA H, Sugiyama T, Ito Y, Toriihara A, et al Detection of Pancreatitis and Protein-Losing Gastroenteropathy Associated With
Systemic Lupus Erythematosus by Protein Leakage Scintigraphy.
J Rheumatol. 2024 Aug 1:jrheum.2024-0468. doi: 10.3899/jrheum.2024-0468. PubMedAbstract available
CHRISTOPHER-STINE L, Ciesluk A, Chinoy H, Goyal NA, et al The Dermatomyositis Disease Symptom Questionnaire (DM-DSQ): A Measure to Assess
the Patient Experience of Dermatomyositis Symptoms.
J Rheumatol. 2024 Aug 1:jrheum.2023-1137. doi: 10.3899/jrheum.2023-1137. PubMedAbstract available
GARG S, Plantinga LC A Bitter Pill to Swallow: The Challenge of Medication Nonadherence in Systemic
Lupus Erythematosus.
J Rheumatol. 2024 Aug 1:jrheum.2024-0654. doi: 10.3899/jrheum.2024-0654. PubMedAbstract available
July 2024
BOWDISH DME, Chandran V, Hitchon CA, Kaplan GG, et al When Should I Get My Next COVID-19 Vaccine? Data From the Surveillance of
Responses to COVID-19 Vaccines in Systemic Immune-Mediated Inflammatory Diseases
(SUCCEED) Study.
J Rheumatol. 2024;51:721-727. PubMedAbstract available
BAGGETT KH, Brandon TG, Xiao R, Weiss PF, et al Association of Infant Breastfeeding and Juvenile Spondyloarthritis: A
Case-Control Study.
J Rheumatol. 2024;51:708-714. PubMedAbstract available
TANI C, Cardelli C, Zen M, Moroni L, et al Anifrolumab In Refractory Systemic Lupus Erythematosus: A Real-Life, Multicenter
Study.
J Rheumatol. 2024 Jul 1:jrheum.2024-0053. doi: 10.3899/jrheum.2024-0053. PubMedAbstract available
TELES MS, Brundage J, Chiang TP, Alejo JL, et al Prevalence and Risk Factors of Post-Acute Sequela of COVID-19 in Adults with
Systemic Autoimmune Rheumatic Diseases.
J Rheumatol. 2024 Jul 1:jrheum.2023-1212. doi: 10.3899/jrheum.2023-1212. PubMedAbstract available
June 2024
UGARTE-GIL MF, Alarcon GS Low Disease Activity Early in the Course of Systemic Lupus Erythematosus.
J Rheumatol. 2024 Jun 15:jrheum.2024-0502. doi: 10.3899/jrheum.2024-0502. PubMedAbstract available
DHITAL R, Baer RJ, Bandoli G, Chambers C, et al Cardiovascular Events During Pregnancy: Implications for Adverse Pregnancy
Outcomes in Individuals With Autoimmune and Rheumatic Diseases.
J Rheumatol. 2024 Jun 15:jrheum.2024-0306. doi: 10.3899/jrheum.2024-0306. PubMedAbstract available
KOBAYASHI H, Yoshida Y, Kida T, Yajima N, et al Seasonal Effects on Relapse of Antineutrophil Cytoplasmic Antibody-Associated
Vasculitis: A Retrospective Multicenter Cohort Study in Japan (J-CANVAS).
J Rheumatol. 2024;51:646-648. PubMed
KWOK TSH, Zhou AL, Nguyen EL, Kwan A, et al Preliminary Development of a Novel Tool to Document Vessel Wall Involvement in
Patients With Large-Vessel Vasculitis.
J Rheumatol. 2024;51:637-639. PubMed
MISZTAL MC, Gold N, Cao J, Diaz T, et al Genetics of Neonatal Lupus Erythematosus Risk and Specific Manifestations.
J Rheumatol. 2024 Jun 1:jrheum.2023-1036. doi: 10.3899/jrheum.2023-1036. PubMedAbstract available
SUN K, Molokwu NJ, Hanlen-Rosado E, Corneli AL, et al Implementation of a clinician-led medication adherence intervention among
patients with systemic lupus erythematosus.
J Rheumatol. 2024 Jun 1:jrheum.2024-0071. doi: 10.3899/jrheum.2024-0071. PubMedAbstract available
May 2024
KANIECKI T, Moyers B, Lubinus M, Hu YP, et al Patient Perspectives of the Manifestations and Treatment of Anti-MDA5
Antibody-Positive Dermatomyositis: An Observational Survey.
J Rheumatol. 2024 May 15:jrheum.2024-0108. doi: 10.3899/jrheum.2024-0108. PubMedAbstract available
AKPOIGBE O, Anim-Koranteng C, Tasmin R, Sammut A, et al A Rare Case of Anti-Mi-2 Antibody-Positive Dermatomyositis Associated With
Gastrointestinal Stromal Tumor.
J Rheumatol. 2024 May 15:jrheum.2024-0114. doi: 10.3899/jrheum.2024-0114. PubMedAbstract available
AVASARALA J, Das S, Keshavamurthy S Point-of-Care Ultrasound With Artificial Intelligence-Driven Diagnostics in Giant
Cell Arteritis: Blindness Prevention on a Global Scale.
J Rheumatol. 2024 May 15:jrheum.2024-0217. doi: 10.3899/jrheum.2024-0217. PubMedAbstract available
BRIDGES JM, Li J, Mannion ML, Clowse MEB, et al Contraception Care Patterns for Adult Females With Juvenile Idiopathic Arthritis
on Teratogens in the Rheumatology Informatics System for Effectiveness (RISE)
Registry.
J Rheumatol. 2024;51:542-545. PubMed
April 2024
SEMALULU T, Berard R, Beattie K, Basodan D, et al Clinical Characteristics of Adolescents With Juvenile Idiopathic Arthritis
Transitioning to Adult Rheumatology Care in Canada: Results From the CAPRI
Registry.
J Rheumatol. 2024;51:403-407. PubMedAbstract available
OWN M, Bloostein A, Spiera R, Berman JR, et al Systemic Sclerosis in Individuals With Exposure to World Trade Center Ground Zero
Rescue and Recovery Efforts: A Case Series.
J Rheumatol. 2024;51:390-395. PubMedAbstract available
CONTRERAS MARTIN GN Lupus Nephritis Treatment Strategies.
J Rheumatol. 2024 Apr 1:jrheum.2024-0172. doi: 10.3899/jrheum.2024-0172. PubMedAbstract available
JUNEK M, Barra L, Kopp A, Felfeli T, et al Phase Specific Health Care Costs Associated with Giant Cell Arteritis in Ontario,
Canada.
J Rheumatol. 2024 Apr 1:jrheum.2023-1245. doi: 10.3899/jrheum.2023-1245. PubMedAbstract available
ROBERTS JE, Faino A, Bryan MA, Cogen JD, et al Hospitalization and Mortality due to Infection among United States Children and
Adolescents with Systemic Lupus Erythematosus.
J Rheumatol. 2024 Apr 1:jrheum.2023-1219. doi: 10.3899/jrheum.2023-1219. PubMedAbstract available
March 2024
YAMAMOTO H, Taniguchi Y Cranial Giant Cell Arteritis and Subdural Hematoma.
J Rheumatol. 2024 Mar 15:jrheum.2024-0008. doi: 10.3899/jrheum.2024-0008. PubMedAbstract available
YENNEMADI AS, Jordan N, Diong S, Keane J, et al The Link Between Dysregulated Immunometabolism and Vascular Damage: Implications
for the Development of Atherosclerosis in Systemic Lupus Erythematosus and Other
Rheumatic Diseases.
J Rheumatol. 2024;51:234-241. PubMedAbstract available
FALASINNU T, Nguyen T, Jiang TE, Tamang S, et al The Problem of Pain in Rheumatology: Variations in Case Definitions Derived From
Chronic Pain Phenotyping Algorithms Using Electronic Health Records.
J Rheumatol. 2024;51:297-304. PubMedAbstract available
YASUDA N, Yamane T Leg Gangrene in Granulomatosis With Polyangiitis.
J Rheumatol. 2024;51:316-317. PubMed
PATEL NJ, Wang X, Lin M, Kowalski EN, et al Factors Associated with an Electronic Health Record-Based Definition of
Post-Acute Sequelae of COVID-19 in Patients with Systemic Autoimmune Rheumatic
Disease.
J Rheumatol. 2024 Mar 1:jrheum.2023-1092. doi: 10.3899/jrheum.2023-1092. PubMedAbstract available
DAWOUD SA, Ahmad NU, Shriver EM, Chung SM, et al Orbital and Optic Nerve Sheath Involvement and Pupil-Involving Cranial Nerve 3
Palsy in Giant Cell Arteritis.
J Rheumatol. 2024 Mar 1:jrheum.2023-1195. doi: 10.3899/jrheum.2023-1195. PubMedAbstract available
MORAND EF, Jones SA Flare in Systemic Lupus Erythematosus: Lost in Translation?
J Rheumatol. 2024 Mar 1:jrheum.2024-0122. doi: 10.3899/jrheum.2024-0122. PubMedAbstract available
February 2024
TAKEUCHI T, Wakasugi N, Hashida T, Uno S, et al Long-term safety and effectiveness of tacrolimus in patients with lupus nephritis
in Japan: 10-year analysis of the real-world TRUST study.
J Rheumatol. 2024 Feb 15:jrheum.2023-0210. doi: 10.3899/jrheum.2023-0210. PubMedAbstract available
WALSH M, Strouse J, Bettendorf B Paget Disease as a Rare Mimicker of Giant Cell Arteritis.
J Rheumatol. 2024 Feb 15:jrheum.2023-1160. doi: 10.3899/jrheum.2023-1160. PubMedAbstract available
SAGY I, Schwarzfuchs O, Zeller L, Ling E, et al Short- and Long-Term Mortality of Hospitalized Patients with Autoimmune Rheumatic
Diseases and Serious Infections: A National Cohort Study.
J Rheumatol. 2024 Feb 1:jrheum.2023-1063. doi: 10.3899/jrheum.2023-1063. PubMedAbstract available
ALPERS CE Antiphospholipid Antibodies (aPL) and Thrombotic Microangiopathy for the
Diagnosis of aPL Nephropathy: You Can't Have One Without the Other.
J Rheumatol. 2024;51:109-111. PubMed
PEDERSEN MJ, Host C, Hansen SN, Deleuran BW, et al Psychiatric Morbidity Is Common Among Children With Juvenile Idiopathic
Arthritis: A National Matched Cohort Study.
J Rheumatol. 2024;51:181-188. PubMedAbstract available
December 2023
ROGERS JL, Clowse MEB, McKenna K, Starling S, et al Patient and physician perspectives of systemic lupus erythematosus flare: A
qualitative study.
J Rheumatol. 2023 Dec 15:jrheum.2023-0721. doi: 10.3899/jrheum.2023-0721. PubMedAbstract available
SKYDEL JJ, Ramachandran R, Suttiratana S, Ross JS, et al Geographic and Demographic Representation in Industry-Sponsored, US-Based
Clinical Trials of Systemic Lupus Erythematosus Therapies.
J Rheumatol. 2023 Dec 15:jrheum.2023-0920. doi: 10.3899/jrheum.2023-0920. PubMedAbstract available
November 2023
TOUMA Z, Parodis I, Strand V More Evidence on the Validity of the Measurement Properties of PROMIS
Computerized Adaptive Tests in Systemic Lupus Erythematosus.
J Rheumatol. 2023 Nov 15:jrheum.2023-0947. doi: 10.3899/jrheum.2023-0947. PubMedAbstract available
RUBENSTEIN E, Maldini C, Vaglio A, Bello F, et al Cluster Analysis to Explore Clinical Subphenotypes of Eosinophilic Granulomatosis
With Polyangiitis.
J Rheumatol. 2023;50:1446-1453. PubMedAbstract available
ROZENBLYUM EV, Chan MO, Gakhal NK Chew on This: The Afterbite of Temporomandibular Joint Involvement in Adults With
Juvenile Idiopathic Arthritis.
J Rheumatol. 2023;50:1364-1366. PubMed
RUPERTO N, Lovell DJ, Berman A, Anton J, et al Abatacept as Monotherapy and in Combination With Methotrexate in Patients With
Juvenile Idiopathic Arthritis: Analysis of 2 Phase III Trials.
J Rheumatol. 2023;50:1471-1480. PubMedAbstract available
DE SONNAVILLE WFC, Speksnijder CM, Zuithoff NPA, Heijstek MW, et al Clinically Established Temporomandibular Involvement in Adults With Juvenile
Idiopathic Arthritis.
J Rheumatol. 2023;50:1462-1470. PubMedAbstract available
OGURO N, Yajima N, Ishikawa Y, Sakurai N, et al Impact of Attending Rheumatologist's Big Five Personality Traits on Systemic
Lupus Erythematosus Patients' Trust: The TRUMP2-SLE Project.
J Rheumatol. 2023 Nov 1:jrheum.2023-0603. doi: 10.3899/jrheum.2023-0603. PubMedAbstract available
October 2023
SUN YS, Huang DF, Chen WS, Liao HT, et al Risk factor and incidence of serious infections in systemic lupus erythematosus
patients undergoing rituximab therapy.
J Rheumatol. 2023 Oct 15:jrheum.2023-0623. doi: 10.3899/jrheum.2023-0623. PubMedAbstract available
PARREAU S, Dumonteil S, Gondran G, Bezanahary H, et al Frequency and Significance of Hepatic Involvement in New-Onset Giant Cell
Arteritis: A Study of 514 Patients.
J Rheumatol. 2023 Oct 15:jrheum.2023-0358. doi: 10.3899/jrheum.2023-0358. PubMedAbstract available
KAWANO Y, Wang X, Patel NJ, Qian G, et al Breakthrough COVID-19 after tixagevimab/cilgavimab among patients with systemic
autoimmune rheumatic diseases.
J Rheumatol. 2023 Oct 15:jrheum.2023-0742. doi: 10.3899/jrheum.2023-0742. PubMedAbstract available
NIETO-GONZALEZ JC, Garulo DC, Boteanu A, Trives-Folguera L, et al What to Expect When Systemic Treatment in Juvenile Idiopathic Arthritis Is
Withdrawn?
J Rheumatol. 2023;50:1326-1332. PubMedAbstract available
AGUIRRE A, DeQuattro K, Shiboski S, Katz P, et al Medication Cost Concerns and Disparities in Patient-Reported Outcomes Among a
Multiethnic Cohort of Patients With Systemic Lupus Erythematosus.
J Rheumatol. 2023;50:1302-1309. PubMedAbstract available
LIU S, Han L, Li M, Tian X, et al Sex Differences in Clinical Manifestations of Hospitalized Patients With
Eosinophilic Granulomatosis With Polyangiitis: A Retrospective Cohort Study.
J Rheumatol. 2023;50:1318-1325. PubMedAbstract available
QUINTANA R, Ramirez-Flores MF, Fuentes-Silva Y, Pelaez-Ballestas I, et al Diagnostic Delay in Autoimmune Rheumatic Diseases: A Global Health Problem.
J Rheumatol. 2023 Oct 1:jrheum.2023-0847. doi: 10.3899/jrheum.2023-0847. PubMedAbstract available
September 2023
PESKIN M, Mostowy M, Velez J, Perron M, et al Clinical improvement in early onset interstitial lung disease using rituximab in
children with anti-MDA5 positive juvenile dermatomyositis.
J Rheumatol. 2023 Sep 15:jrheum.2023-0544. doi: 10.3899/jrheum.2023-0544. PubMedAbstract available
SASAI T, Nakashima R, Tsuji H, Nakajima T, et al Long term prognosis of anti-melanoma differentiation-associated gene 5-positive
dermatomyositis with interstitial lung disease.
J Rheumatol. 2023 Sep 15:jrheum.2023-0371. doi: 10.3899/jrheum.2023-0371. PubMedAbstract available
YOSHIDA Y, Nakamoto N, Oka N, Kidoguchi G, et al Seasonal Influence on Development of Antineutrophil Cytoplasmic
Antibody-Associated Vasculitis: A Retrospective Cohort Study Conducted at
Multiple Institutions in Japan (J-CANVAS).
J Rheumatol. 2023;50:1152-1158. PubMedAbstract available
WEISS PF, Brandon TG, Lambert RG, Biko DM, et al Consensus-Driven Definition for Unequivocal Sacroiliitis on Radiographs in
Juvenile Spondyloarthritis.
J Rheumatol. 2023;50:1173-1177. PubMedAbstract available
MOISEEV S, Bulanov N, Crnogorac M, Direskeneli H, et al Traditional and Disease-Specific Risk Factors for Cardiovascular Events in
Antineutrophil Cytoplasmic Antibody-Associated Vasculitis: A Multinational
Retrospective Study.
J Rheumatol. 2023;50:1145-1151. PubMedAbstract available
FERUCCI ED Improving Outcomes in Systemic Lupus Erythematosus: The Importance of Access to
Medications.
J Rheumatol. 2023 Sep 1:jrheum.2023-0772. doi: 10.3899/jrheum.2023-0772. PubMedAbstract available